The Yale Cancer Center Lifetime Achievement Award is the highest honors bestowed within our organization. Our committee had very little trouble in determining that the 2017 Award should go to Vincent DeVita, Jr, MD, recognizing his work developing the first successful chemotherapy treatment for Hodgkin's lymphoma, a breakthrough that was heralded by the American Society of Clinical Oncology as the top research advance in half a century.
During his career, Dr. DeVita served as Director of the National Cancer Institute, as President of the American Cancer Society, and as Director of the Yale Cancer Center.
"As one of oncology’s leading figures, Dr. DeVita knows what cancer looks like from the lab bench and the bedside," commented Dr. Roy Herbst during the ceremony. "It is truly an honor to give this award to Dr. DeVita!"